Soft chewy confection comprising hmo
US-2024000098-A1 · Jan 4, 2024 · US
Use of agarobiose or agarooligosaccharide having anticariogenic activity
US11458152B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11458152-B2 |
| Application number | US-202016985850-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 5, 2020 |
| Priority date | Nov 15, 2016 |
| Publication date | Oct 4, 2022 |
| Grant date | Oct 4, 2022 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a use of an agarobiose or agarooligosaccharides having anticariogenic activity. More specifically, a lower concentration of agarobiose or agarooligosaccharides than the concentration of xylitol suppresses the growth of Streptococcus mutans and suppresses acid production, and thus can be used for anti-cariogenic purposes.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating or alleviating an oral disease of a subject, comprising administering a therapeutically effective amount of agarobiose, agarooligosaccharides, or combination thereof to the subject, wherein the oral disease is any one selected from the group consisting of dental caries, gingivitis, periodontitis, oral mucous ulcers, halitosis, and xerostomia, and wherein the agarooligosaccharides are a mixture of agarobiose, agarotetraose, agarohexaose, and agarooctaose. 2. The method of claim 1 , wherein the agarooligosaccharides are obtained from an acid hydrolysate of agarose. 3. The method of claim 1 , wherein the agarobiose is obtained by separating and purifying an acid hydrolysate of agarose through gel permeation chromatography. 4. The method of claim 1 , wherein the oral disease is caused by one or more oral microorganisms selected from the group consisting of Streptococcus mutans, Porphyromonas gingivalis, Prevotella intermedia, Actinobacillus actinomycetemcomitans , and Candida albicans.
Assignees
Inventors
Classifications
- A61K31/702Primary
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages · CPC title
- A61K8/73Primary
Polysaccharides · CPC title
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title
using additives (addition of substantially indigestible substances A23L33/21) · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11458152B2 cover?
- The present invention relates to a use of an agarobiose or agarooligosaccharides having anticariogenic activity. More specifically, a lower concentration of agarobiose or agarooligosaccharides than the concentration of xylitol suppresses the growth of Streptococcus mutans and suppresses acid production, and thus can be used for anti-cariogenic purposes.
- Who is the assignee on this patent?
- Univ Korea Res & Bus Found
- What technology area does this patent fall under?
- Primary CPC classification A61K31/702. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).